Original Research

Experiences of Veterans With Diabetes From Shared Medical Appointments

Author and Disclosure Information

 

References

Limitations

One of the strengths of this study is that to the authors’ knowledge, this is the first report of findings from a focus group on motivating factors and barriers for veterans with diabetes who had attended an SMA in a primary care setting. Although the study was small, the participation rate was high.

The study had a few limitations. The results might not be applicable to other populations, because all participants were veterans, predominantly male with T2DM. Selection bias is possible, because participants had already attended SMA classes. Participants may have been biased in their providing positive feedback of the SMA classes, since SMA facilitators held this focus group.

Conclusions

The study findings have several implications. Weight gain was ranked as the greatest barrier to self-managing diabetes in this focus group. Veterans stated they had limited resources, which could impact their AADE 7 self-care activities of being active and healthy eating. As resources allow, cooking classes, gym memberships, and VA-affiliated exercise facilities may be beneficial. Since there was heterogeneity in veteran experiences during diabetes diagnosis, consistent information should be provided upfront, including general concepts of diabetes and available resources.

This diabetes focus group highlighted the challenges of having a double identity, of being both a veteran and having diabetes. Shared medical appointments with veteran cohorts were identified as a promising intervention that allows for camaraderie and shared narratives to be enhanced by clinical guidance and education. By providing social support, SMAs may nudge fellow veterans to act on barriers that have them “stuck” in certain behaviors or situations. Many veterans view A1c as an important motivator, and this should be considered as a general educational tool.

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of
Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Pages

Recommended Reading

Diabetes Report: The News Isn’t Good
Federal Practitioner
Examining the Link Between Incretins and Pancreatitis
Federal Practitioner
Measuring Nurses’ Knowledge of Diabetes Management
Federal Practitioner
Education Pitfalls of Insulin Administration in Patients With Diabetes
Federal Practitioner
A Call to Action: Intensive Lifestyle Intervention Against Diabesity
Federal Practitioner
Long-Acting Insulin Analogs: Effects on Diabetic Retinopathy
Federal Practitioner
Lifestyle Intervention for Veterans With Chronic Diseases
Federal Practitioner
Low TSH? It Might Not Be Thyrotoxicosis
Federal Practitioner
Diabetes Patient-Centered Medical Home Approach
Federal Practitioner
All IHS Hospitals Now Baby-Friendly
Federal Practitioner

Related Articles